Experts have identified three major sources of high cancer costs and argue that cancer doctors can likely reduce them without harm to patients. The cost-cutting proposals call for changes in routine clinical practice involved in end-of-life care, medical imaging, and drug pricing.
A novel blood-based biomarker test has been shown to predict with over 90% accuracy the likelihood of a healthy individual developing mild cognitive impairment or Alzheimer's disease within three years.
Make prescribing decisions with our charts and treatment algorithms.
Only for those who purchased the UMDNJ PANCE/PANRE Review Course prior to March 22, 2013: ...